New Mexico law prompts review of two hospital mergers; Albuquerque expansion proposed

New Mexico regulators have invoked a law passed in 2024 and strengthened in 2025 to review two hospital-related transactions, underscoring state concerns about private equity ownership and the future of local health care capacity. One deal was approved in December 2024, and a second is under active review by the Health Care Authority.

The transaction under scrutiny would transfer 100 percent ownership of New Mexico Behavioral Healthcare in Albuquerque to Woodland SNF Operator Trust and Woodland SNF Operator Trust II and would expand the facility from 18 inpatient beds by an additional 58 beds. The Health Care Authority held a public meeting on the proposed transaction on Nov. 4, and no comments were submitted, the agency notice said. The agency will render a decision on the transaction by Feb. 6, according to the notice.

The reviews flow from the Health Care Consolidation Oversight Act, enacted as SB 15 in 2024, which temporarily empowered the Office of the Superintendent of Insurance to evaluate mergers and ownership changes that could affect hospitals. In 2025 the legislature moved to make oversight permanent and transfer responsibility to the New Mexico Health Care Authority through legislation commonly identified as HB 586. Tim Fowler, a spokesperson for the Health Care Authority, said the agency has received one transaction for evaluation since taking over in July 2025.

The statute requires specific reporting and post-transaction monitoring. The oversight law also mandates that an entity identified as Oceans file annual reports from 2025 through 2027 about Haven Albuquerque showing the “growth, decline and other material changes in health care services provided by Haven Albuquerque,” the “cost trends” at Haven and any other material changes. Those reports are confidential, and the Health Care Authority confirmed Oceans submitted the 2025 report.

Policy language guiding reviews was drafted to weigh service access, quality, affordability and market competition. OSI’s review “considers the impact the proposed transaction will have on access to services, quality of care, patient affordability, and competition in the market,” a provision of the earlier statute states. The 2024 law also granted OSI authority to conduct post-transaction oversight for three years to monitor compliance with any conditions placed on approved transactions and other outcomes.

Advocates and lawmakers framed the oversight push as a response to New Mexico’s “nation-leading rate of private equity-owned hospitals,” while industry groups have pushed back, arguing some critics overstate private equity risk. Observers and some policy analysts argue the law still leaves loopholes that allow transactions to proceed without state review, and a handful of policy commentators have urged legislators to consider stronger reporting rules similar to Massachusetts’ market review reforms.

For Los Alamos County residents, the immediate significance is practical: an approved expansion in Albuquerque could alter where patients are admitted for inpatient behavioral health care and affect regional bed availability. The longer-term stakes include how the state monitors ownership changes that can influence cost, access and local hospital services.

What to watch next: the Health Care Authority’s decision by Feb. 6 and any public materials the agency releases explaining conditions or findings. Lawmakers and local health advocates are likely to continue pressing for clearer reporting and tighter oversight if regulators approve substantial ownership or capacity changes.